The use of mtt{3-(4,5-dimetyl-2-thiazolyl)-2,5-dipherryl-2h-tetrazolium bromide}-reduction as an indicator of the effects of strain-specific, polyclonal rabbit antisera on Candida albicans and C. krusei
dc.contributor.author | Arsekularatne, S.N. | |
dc.contributor.author | Atapattu, D.N. | |
dc.contributor.author | Kumarasiri, R. | |
dc.contributor.author | Perera, D. | |
dc.contributor.author | Ekanayake, D. | |
dc.contributor.author | Rajapakse, J. | |
dc.date.accessioned | 2015-05-19T09:25:32Z | |
dc.date.available | 2015-05-19T09:25:32Z | |
dc.date.issued | 2007 | |
dc.identifier.citation | Indian Journal of Medical Microbiology, 25(3):p.267-271 | |
dc.identifier.reportnumber | FR 1620 | |
dc.identifier.researchgrantnumber | NSF/FELLOW/2006/01 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/19385 | |
dc.subject | Medical Sciences | |
dc.subject | Strain-specific antibody | |
dc.subject | Candida albicans | |
dc.subject | Candida krusei | |
dc.title | The use of mtt{3-(4,5-dimetyl-2-thiazolyl)-2,5-dipherryl-2h-tetrazolium bromide}-reduction as an indicator of the effects of strain-specific, polyclonal rabbit antisera on Candida albicans and C. krusei | |
dc.type | Article |